DEAD-Box Helicase 27 Enhances Stem Cell-Like Properties with Poor Prognosis in Breast Cancer

Total Page:16

File Type:pdf, Size:1020Kb

DEAD-Box Helicase 27 Enhances Stem Cell-Like Properties with Poor Prognosis in Breast Cancer DEAD-Box Helicase 27 Enhances Stem Cell-Like Properties With Poor Prognosis in Breast Cancer Shan Li The First Aliated Hospital of China Medical University Jinfei Ma The First Aliated Hospital of China Medical University Ang Zheng The First Aliated Hospital of China Medical University Xinyue Song China Medical University Si Chen China Medical University Feng Jin ( [email protected] ) The First Aliated Hospital of China Medical University https://orcid.org/0000-0002-0325-5362 Research Article Keywords: DEAD-box helicase 27 (DDX27), Breast cancer, Stem cell-like properties, Prognosis Posted Date: June 7th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-521379/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Version of Record: A version of this preprint was published at Journal of Translational Medicine on August 6th, 2021. See the published version at https://doi.org/10.1186/s12967-021-03011-0. Page 1/22 Abstract Background Although the rapid development of diagnosis and treatment has improved prognosis in early breast cancer, challenges from different therapy response remain due to breast cancer heterogeneity. DEAD-box helicase 27 (DDX27) had been proved to inuence ribosome biogenesis and identied as a promoter in gastric and colorectal cancer associated with stem cell-like properties, while the impact of DDX27 on breast cancer prognosis and biological functions is unclear. We aimed to explore the inuence of DDX27 on stem cell-like properties and prognosis in breast cancer. Methods The expression of DDX27 was evaluated in 24 pairs of fresh breast cancer and normal tissue by western blot. We conducted Immunohistochemical (IHC) staining in paran sections of 165 breast cancer patients to analyze the expression of DDX27 and its correlation to stemness biomarker. The Cancer Genome Atlas-Brest Cancer (TCGA-BRCA) and Kaplan-Meier survival analysis were used to investigate the expression of DDX27 in breast cancer and its implication on prognosis. Western blot, CCK-8 assay, Transwell assay and wound-healing assay were used to clarify the regulation of DDX27 on stem cell-like properties in breast cancer cells. Gene Set Enrichment Analysis (GSEA) was performed to analyze the potential molecular mechanisms of DDX27 in breast cancer. Results DDX27 was signicantly high expressed in breast cancer compared with normal tissue. High expression of DDX27 was related to larger tumor size (p = 0.0005), positive lymph nodes (p = 0.0008), higher histological grade (p = 0.0040), higher ki-67 (p = 0.0063) and later TNM stage (p 0.0001). Patients with high DDX27 expression turned out worse prognosis on overall survival (OS, p = 0.0087) and disease-free survival (DFS, p = 0.0235). Overexpression of DDX27 could enhance the expression of biomarkers related to stemness and promote stem cell-like activities such as proliferation and migration in breast cancer cells. Conclusion DDX27 can enhance stem cell-like properties and cause poor prognosis in breast cancer, also may be expected to become a potential biomarker for breast cancer therapy. Background Page 2/22 Breast cancer has already surpassed lung cancer and developed into the major malignant tumor in women all around the world with 2.3 million new cases in 2020 based on GLOBOCAN 2020[1]. Although the rapid development of diagnosis and treatment has improved prognosis in early breast cancer, challenges from different therapy response remain due to breast cancer heterogeneity. DEAD-box helicase 27 (DDX27) pertains to the DEAD-box RNA helicases family, which is a classical ATP- dependent helicases family containing conserved D-E-A-D (Asp-Glu-Ala-Asp) sequences. This family has been conrmed to participate in various processes containing RNA transportation, RNA degradation, glucose metabolism, lipid metabolism, ribosome biosynthesis, tumorigenesis, cancer development and so on[2–8]. DDX27 was proved to take part in the processes of ribosome biogenesis, which performed an important function in cell proliferating. DDX27 could regulate the 47S ribosome RNA formation and associated with PeBow-complex independently[9]. In the process of skeletal muscle myogenesis, DDX27 was reported to inuence ribosome RNA maturation, ribosome biogenesis and specic transcription[10]. DDX27 was also related to the development of malignant tumor. DDX27 had been conrmed to promote the development and metastasis in hepatocellular carcinoma and gastrointestinal cancer with poor prognosis[11–13]. Until now, the status of DDX27 expression and its implication on breast cancer remains unclear. Breast cancer stem cells refer to a fraction of cells who has strong self-renewal capacity and a huge potential of multiple differentiation in breast cancer which can promote the courses of tumorigenesis, development, metastasis and drug resistance[14–16]. Studies proved that members of DEAD-box RNA helicases family could affect the biological behavior of cancer stem cells in various cancers[17–19]. The only member of DEAD-box RNA helicases family which has exactly effects on breast cancer stem cells is DDX17, who can enhance stem cell-like activities by combining with SOX2 or mechanism of promoting stem-like properties under hypoxia[20, 21]. DDX27 was reported to promote stem cell-like characteristics and cause poor prognosis in gastric and colorectal cancer[11, 22], while the inuence on stemness in breast cancer remains unclear. Hence, it is of great signicance to explore the inuence of DDX27 on tumorigenesis, progress and the association with stem cell-like properties in breast cancer, which might suggest a new idea for diagnosis and therapy. In our study, DDX27 was highly expressed in both The Cancer Genome Atlas-Brest Cancer (TCGA-BRCA) database and breast cancer samples. High expression of DDX27 was rstly reported in breast cancer with the connection to clinicopathological factors and caused a shorter survival. The expression of DDX27 was positively related to stemness biomarkers and promoted the stem cell-like activities. Furthermore, Gene Set Enrichment Analysis (GSEA) suggested that DDX27 might have an effect on breast cancer by various ways. Hence, DDX27 can enhance the stem cell-like properties meanwhile leading to a poor prognosis in breast cancer, which means DDX27 may become a potentially signicant prognosis biomarker and therapeutic target. Methods Page 3/22 The Cancer Genome Atlas-Brest Cancer Database All of the gene expression data were downloaded and organized from TCGA-BRCA database (https://cancergenome.nih.gov/), which contains 1109 breast cancer and 103 normal samples. Normalization of all data was performed by edgR package. Kaplan-Meier survival analysis and Gene Set Enrichment Analysis Kaplan-Meier Plotter (http://kmplot.com/analysis/) is an online database containing survival information and gene expression of various cancers and used to analyze the implication of DDX27 on breast cancer prognosis [23]. The potential mechanism of DDX27 expression in breast cancer was analyzed by GSEA 4.0.3 software. Patients and tissue samples Under the permission from the Ethics Review Committee in the First Aliated Hospital of China Medical University (AF - SOP − 07–1.1–01), fresh cancer tissue with paired adjacent normal tissue (n = 24), and paran-embedded specimens (n = 165) were obtained. All included patients were pathologically diagnosed as inltrative ductal carcinoma. None of the patients received breast-conserving surgery or neoadjuvant therapy. Twenty-four pairs of fresh specimens were collected within 30 minutes after surgery and 165 paran-embedded specimens for IHC were collected during Jan.2014 to Dec.2015. Clinical and pathological information obtained from the Hospital Information System included age, tumor size, lymph nodes status, estrogen receptor (ER) status, progesterone receptor (PR) status, human epidermal growth factor receptor 2 (HER2) status, histological grade, ki-67 index and TNM stage. Western blot Samples of tissue and cells were lysed by the compound of RIPA buffer and protease inhibitors (Sigma- Aldrich) for half an hour on ice after washed by phosphate-buffered saline (PBS) twice. Then the samples were centrifuged for 15 minutes in the condition of 14,000×g and 4°C. Protein from tissue and cells was quantied by BCA assay kit (Beyotime, Jiangsu, China). Protein with equal quantity was transferred onto the polyvinylidene uoride (PVDF) membranes (Millipore, Bedford, MA) after electrophoresed by SDS- PAGE. The membrane was sealed with bovine serum albumin (BSA) and hatched with primary antibodies at 4℃ overnight, then the secondary antibodies at room temperature for one hour. The primary antibodies for experiments contained anti-DDX27 (1:2000, Abcam, USA), anti-SOX2 (1:1000, Proteintech, China), anti-OCT4 (1:1000, Cell Signaling Technology, USA) and β-actin (1:2000, Proteintech, China). Membranes were tested with an enhanced chemiluminescence detection kit (BOSTER, USA). Immunohistochemical staining Each paran-embedded sample was cut into 4µm sections, dewaxed routinely, and dehydrated with gradient ethanol. All sections were retrieved antigen in citrate buffer with high pressure. The sections were restored to room temperature and blocked the activity of endogenous peroxidase by 3% hydrogen Page 4/22 peroxide. Then, all the slides were incubated with anti-DDX27 (1:2000, Novus Biologicals, USA) or anti- OCT4 (1:500, Cell Signaling Technology, USA) at 4°C overnight. The sections were incubated with the secondary antibody at room temperature
Recommended publications
  • A Bootstrap-Based Regression Method for Comprehensive Discovery of Differential Gene Expressions: an Application to the Osteoporosis Study
    A bootstrap-based regression method for comprehensive discovery of differential gene expressions: an application to the osteoporosis study Yan Lu1,2, Yao-Zhong Liu3, Peng–Yuan Liu2, Volodymyr Dvornyk4, and Hong–Wen Deng1,3 1. College of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing 100044, P. R. China 2. Department of Physiology and the Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA 3. Department of Biostatistics and Bioinformatics & Center for Bioinformatics and Genomics, Tulane University School of Public Health, New Orleans, LA 70112, USA 4. School of Biological Sciences, University of Hong Kong, Pokfulam Rd., Pokfulam, Hong Kong, P.R. China Running title: Bootstrap-based regression method for microarray analysis Key words: microarray, bootstrap, regression, osteoporosis Corresponding author: Hong–Wen Deng, Ph. D. Department of Biostatistics and Bioinformatics & Center for Bioinformatics and Genomics, Tulane University School of Public Health, 1440 Canal Street, Suite 2001, New Orleans, LA 70112 Tel: 504-988-1310 Email: [email protected] 1 Abstract A common purpose of microarray experiments is to study the variation in gene expression across the categories of an experimental factor such as tissue types and drug treatments. However, it is not uncommon that the studied experimental factor is a quantitative variable rather than categorical variable. Loss of information would occur by comparing gene-expression levels between groups that are factitiously defined according to the quantitative threshold values of an experimental factor. Additionally, lack of control for some sensitive clinical factors may bring serious false positive or negative findings. In the present study, we described a bootstrap-based regression method for analyzing gene expression data from the non-categorical microarray experiments.
    [Show full text]
  • Literature Mining Sustains and Enhances Knowledge Discovery from Omic Studies
    LITERATURE MINING SUSTAINS AND ENHANCES KNOWLEDGE DISCOVERY FROM OMIC STUDIES by Rick Matthew Jordan B.S. Biology, University of Pittsburgh, 1996 M.S. Molecular Biology/Biotechnology, East Carolina University, 2001 M.S. Biomedical Informatics, University of Pittsburgh, 2005 Submitted to the Graduate Faculty of School of Medicine in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Pittsburgh 2016 UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE This dissertation was presented by Rick Matthew Jordan It was defended on December 2, 2015 and approved by Shyam Visweswaran, M.D., Ph.D., Associate Professor Rebecca Jacobson, M.D., M.S., Professor Songjian Lu, Ph.D., Assistant Professor Dissertation Advisor: Vanathi Gopalakrishnan, Ph.D., Associate Professor ii Copyright © by Rick Matthew Jordan 2016 iii LITERATURE MINING SUSTAINS AND ENHANCES KNOWLEDGE DISCOVERY FROM OMIC STUDIES Rick Matthew Jordan, M.S. University of Pittsburgh, 2016 Genomic, proteomic and other experimentally generated data from studies of biological systems aiming to discover disease biomarkers are currently analyzed without sufficient supporting evidence from the literature due to complexities associated with automated processing. Extracting prior knowledge about markers associated with biological sample types and disease states from the literature is tedious, and little research has been performed to understand how to use this knowledge to inform the generation of classification models from ‘omic’ data. Using pathway analysis methods to better understand the underlying biology of complex diseases such as breast and lung cancers is state-of-the-art. However, the problem of how to combine literature- mining evidence with pathway analysis evidence is an open problem in biomedical informatics research.
    [Show full text]
  • Dissertation
    Regulation of gene silencing: From microRNA biogenesis to post-translational modifications of TNRC6 complexes DISSERTATION zur Erlangung des DOKTORGRADES DER NATURWISSENSCHAFTEN (Dr. rer. nat.) der Fakultät Biologie und Vorklinische Medizin der Universität Regensburg vorgelegt von Johannes Danner aus Eggenfelden im Jahr 2017 Das Promotionsgesuch wurde eingereicht am: 12.09.2017 Die Arbeit wurde angeleitet von: Prof. Dr. Gunter Meister Johannes Danner Summary ‘From microRNA biogenesis to post-translational modifications of TNRC6 complexes’ summarizes the two main projects, beginning with the influence of specific RNA binding proteins on miRNA biogenesis processes. The fate of the mature miRNA is determined by the incorporation into Argonaute proteins followed by a complex formation with TNRC6 proteins as core molecules of gene silencing complexes. miRNAs are transcribed as stem-loop structured primary transcripts (pri-miRNA) by Pol II. The further nuclear processing is carried out by the microprocessor complex containing the RNase III enzyme Drosha, which cleaves the pri-miRNA to precursor-miRNA (pre-miRNA). After Exportin-5 mediated transport of the pre-miRNA to the cytoplasm, the RNase III enzyme Dicer cleaves off the terminal loop resulting in a 21-24 nt long double-stranded RNA. One of the strands is incorporated in the RNA-induced silencing complex (RISC), where it directly interacts with a member of the Argonaute protein family. The miRNA guides the mature RISC complex to partially complementary target sites on mRNAs leading to gene silencing. During this process TNRC6 proteins interact with Argonaute and recruit additional factors to mediate translational repression and target mRNA destabilization through deadenylation and decapping leading to mRNA decay.
    [Show full text]
  • A Master Autoantigen-Ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases
    bioRxiv preprint doi: https://doi.org/10.1101/2021.07.30.454526; this version posted August 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases Julia Y. Wang1*, Michael W. Roehrl1, Victor B. Roehrl1, and Michael H. Roehrl2* 1 Curandis, New York, USA 2 Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA * Correspondence: [email protected] or [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.07.30.454526; this version posted August 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract Chronic and debilitating autoimmune sequelae pose a grave concern for the post-COVID-19 pandemic era. Based on our discovery that the glycosaminoglycan dermatan sulfate (DS) displays peculiar affinity to apoptotic cells and autoantigens (autoAgs) and that DS-autoAg complexes cooperatively stimulate autoreactive B1 cell responses, we compiled a database of 751 candidate autoAgs from six human cell types. At least 657 of these have been found to be affected by SARS-CoV-2 infection based on currently available multi-omic COVID data, and at least 400 are confirmed targets of autoantibodies in a wide array of autoimmune diseases and cancer.
    [Show full text]
  • Ddx27 (BC011321) Mouse Tagged ORF Clone – MR208999
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for MR208999 Ddx27 (BC011321) Mouse Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: Ddx27 (BC011321) Mouse Tagged ORF Clone Tag: Myc-DDK Symbol: Ddx27 Synonyms: C86129 Vector: pCMV6-Entry (PS100001) E. coli Selection: Kanamycin (25 ug/mL) Cell Selection: Neomycin This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 5 Ddx27 (BC011321) Mouse Tagged ORF Clone – MR208999 ORF Nucleotide >MR208999 representing BC011321 Sequence: Red=Cloning site Blue=ORF Green=Tags(s) TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGGCGCCGCCCGCCGCCCGTCTCGCGCTGCTCTCCGCCGCTGCGCTCACTCTGGCGGCCCGGCCCGCGC CCGGTCCCCGCTCCGGCCCCGAGTGCTTCACAGCCAACGGTGCAGATTACAGGGGAACACAGAGCTGGAC AGCGCTGCAAGGTGGGAAGCCATGTCTGTTCTGGAACGAGACTTTCCAGCATCCGTACAACACGCTGAAG TACCCCAACGGGGAAGGAGGACTGGGCGAGCACAATTATTGCAGAAATCCAGATGGAGACGTGAGCCCTT GGTGCTACGTGGCCGAGCATGAGGACGGAGTCTACTGGAAGTACTGTGAAATTCCTGCCTGCCAGATGCC TGGAAACCTTGGCTGCTACAAGGATCATGGAAACCCACCTCCTCTCACGGGCACCAGTAAAACCTCTAAC AAGCTCACCATACAAACCTGTATCAGCTTCTGTCGGAGTCAGAGATTCAAGTTTGCTGGGATGGAGTCAG GCTATGCCTGCTTCTGTGGGAACAATCCTGACTACTGGAAGCACGGGGAGGCGGCCAGCACCGAGTGCAA TAGTGTCTGCTTCGGGGACCACACGCAGCCCTGCGGTGGGGACGGCAGGATTATCCTCTTTGACACTCTC
    [Show full text]
  • The DNA Sequence and Comparative Analysis of Human Chromosome 20
    articles The DNA sequence and comparative analysis of human chromosome 20 P. Deloukas, L. H. Matthews, J. Ashurst, J. Burton, J. G. R. Gilbert, M. Jones, G. Stavrides, J. P. Almeida, A. K. Babbage, C. L. Bagguley, J. Bailey, K. F. Barlow, K. N. Bates, L. M. Beard, D. M. Beare, O. P. Beasley, C. P. Bird, S. E. Blakey, A. M. Bridgeman, A. J. Brown, D. Buck, W. Burrill, A. P. Butler, C. Carder, N. P. Carter, J. C. Chapman, M. Clamp, G. Clark, L. N. Clark, S. Y. Clark, C. M. Clee, S. Clegg, V. E. Cobley, R. E. Collier, R. Connor, N. R. Corby, A. Coulson, G. J. Coville, R. Deadman, P. Dhami, M. Dunn, A. G. Ellington, J. A. Frankland, A. Fraser, L. French, P. Garner, D. V. Grafham, C. Grif®ths, M. N. D. Grif®ths, R. Gwilliam, R. E. Hall, S. Hammond, J. L. Harley, P. D. Heath, S. Ho, J. L. Holden, P. J. Howden, E. Huckle, A. R. Hunt, S. E. Hunt, K. Jekosch, C. M. Johnson, D. Johnson, M. P. Kay, A. M. Kimberley, A. King, A. Knights, G. K. Laird, S. Lawlor, M. H. Lehvaslaiho, M. Leversha, C. Lloyd, D. M. Lloyd, J. D. Lovell, V. L. Marsh, S. L. Martin, L. J. McConnachie, K. McLay, A. A. McMurray, S. Milne, D. Mistry, M. J. F. Moore, J. C. Mullikin, T. Nickerson, K. Oliver, A. Parker, R. Patel, T. A. V. Pearce, A. I. Peck, B. J. C. T. Phillimore, S. R. Prathalingam, R. W. Plumb, H. Ramsay, C. M.
    [Show full text]
  • RNA Helicase, DDX27 Regulates Skeletal Muscle Growth and Regeneration by Modulation of Translational Processes
    RNA helicase, DDX27 regulates skeletal muscle growth and regeneration by modulation of translational processes The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Bennett, A. H., M. O’Donohue, S. R. Gundry, A. T. Chan, J. Widrick, I. Draper, A. Chakraborty, et al. 2018. “RNA helicase, DDX27 regulates skeletal muscle growth and regeneration by modulation of translational processes.” PLoS Genetics 14 (3): e1007226. doi:10.1371/journal.pgen.1007226. http://dx.doi.org/10.1371/ journal.pgen.1007226. Published Version doi:10.1371/journal.pgen.1007226 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:35982208 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA RESEARCH ARTICLE RNA helicase, DDX27 regulates skeletal muscle growth and regeneration by modulation of translational processes Alexis H. Bennett1, Marie-Francoise O'Donohue2, Stacey R. Gundry3, Aye T. Chan4, Jeffrey Widrick3, Isabelle Draper5, Anirban Chakraborty2,6, Yi Zhou4, Leonard I. Zon4,7, Pierre-Emmanuel Gleizes2, Alan H. Beggs3, Vandana A. Gupta1,3* 1 Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America, 2 Laboratoire de Biologie MoleÂculaire Eucaryote, Centre de Biologie InteÂgrative a1111111111 (CBI), UniversiteÂ
    [Show full text]
  • DEAH)/RNA Helicase a Helicases Sense Microbial DNA in Human Plasmacytoid Dendritic Cells
    Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells Taeil Kima, Shwetha Pazhoora, Musheng Baoa, Zhiqiang Zhanga, Shino Hanabuchia, Valeria Facchinettia, Laura Bovera, Joel Plumasb, Laurence Chaperotb, Jun Qinc, and Yong-Jun Liua,1 aDepartment of Immunology, Center for Cancer Immunology Research, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030; bDepartment of Research and Development, Etablissement Français du Sang Rhône-Alpes Grenoble, 38701 La Tronche, France; and cDepartment of Biochemistry, Baylor College of Medicine, Houston, TX 77030 Edited by Ralph M. Steinman, The Rockefeller University, New York, NY, and approved July 14, 2010 (received for review May 10, 2010) Toll-like receptor 9 (TLR9) senses microbial DNA and triggers type I Microbial nucleic acids, including their genomic DNA/RNA IFN responses in plasmacytoid dendritic cells (pDCs). Previous and replicating intermediates, work as strong PAMPs (13), so studies suggest the presence of myeloid differentiation primary finding PRR-sensing pathogenic nucleic acids and investigating response gene 88 (MyD88)-dependent DNA sensors other than their signaling pathway is of general interest. Cytosolic RNA is TLR9 in pDCs. Using MS, we investigated C-phosphate-G (CpG)- recognized by RLRs, including RIG-I, melanoma differentiation- binding proteins from human pDCs, pDC-cell lines, and interferon associated gene 5 (MDA5), and laboratory of genetics and physi- regulatory factor 7 (IRF7)-expressing B-cell lines. CpG-A selectively ology 2 (LGP2). RIG-I senses 5′-triphosphate dsRNA and ssRNA bound the aspartate-glutamate-any amino acid-aspartate/histi- or short dsRNA with blunt ends.
    [Show full text]
  • Ddx27 (NM 153065) Mouse Tagged ORF Clone – MR226500
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for MR226500 Ddx27 (NM_153065) Mouse Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: Ddx27 (NM_153065) Mouse Tagged ORF Clone Tag: Myc-DDK Symbol: Ddx27 Synonyms: C86129 Vector: pCMV6-Entry (PS100001) E. coli Selection: Kanamycin (25 ug/mL) Cell Selection: Neomycin This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 4 Ddx27 (NM_153065) Mouse Tagged ORF Clone – MR226500 ORF Nucleotide >MR226500 representing NM_153065 Sequence: Red=Cloning site Blue=ORF Green=Tags(s) TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGCTGGCGGAGCTCGGCTTCATCCGGACCATCGGCGAGAATGACGAGGTGCCGGTTGAGCCCGAGTCGG ACTCCGGAGACGAGGAGGAGGAGGGACCCATTGTGCTGGGCCGCAAGCAGAAAGCCTTGCAGAAGAACCG CAGTGCTGACTTCAACCCTGACTTTGTTTTCACTGAGAAGGAGGGCATGTATGATGGCAGCTGGGCCCTG GCTGATGTCATGAGCCAGCTCAAGAAGAAGCGGGCAGCCACTACACTAGATGAGAAGATTGAGAAAGTCC GGAAGAGAAGGAAGGCAGAGGACAAGGAAGCCAAGTCTGGGAAGGTGGAGGAGAAAGAAGGCCAGGCAGA CTCTGACCTGAAGGGGCAGGAGAATCCGGGTGAGGATGAGGCAGGCTCCAAGGATGAAGACTCTGAGACT GACTACTCCTCTGAGGATGAGGAAATCCTCACCAAAGCAGACACACTCAAAGTGAAGGAGAAGAAGAAGA AGAAGAAGGGCCAGGCAGCAGGAGGATTCTTTGAAGATGCATCCGAGTATGACAAAAGCCTGTCCTTCCA GGACATGAACCTCTCCCGGCCCCTCCTGAAGGCCATTACAGCCATGGGCTTCAAGCAGCCCACGCCAATC
    [Show full text]
  • 1 RNA Helicase, DDX27 Regulates Proliferation And
    bioRxiv preprint doi: https://doi.org/10.1101/125484; this version posted April 7, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. RNA helicase, DDX27 regulates proliferation and myogenic commitment of muscle stem cells Short Title: Translational Regulation of Myogenesis by DDX27 Alexis H Bennett1, Marie-Francoise O’Donohue2, Stacey R. Gundry3, Aye T. Chan4, JeFFery Widrick3, Isabelle Draper5, Anirban Chakraborty2, Yi Zhou4, Leonard I. Zon4,6, Pierre-Emmanuel Gleizes2, Alan H. Beggs3, Vandana A Gupta1,3* 1. Division oF Genetics, Brigham and Women’s Hospital, Harvard Medical School, Boston MA 02115, USA 2. Laboratoire de Biologie Moléculaire Eucaryote, Centre de Biologie Intégrative (CBI), Université de Toulouse, UPS, CNRS, France 3. Division oF Genetics and Genomics, The Manton Center For Orphan Disease Research, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. 4.Stem Cell Program and Pediatric Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA. 5. Molecular Cardiology Research Institute, TuFts Medical Center, Boston, MA 02111, USA 6. Howard Hughes Medical Institute. *Corresponding Author Vandana A Gupta Division oF Genetics, Department oF Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115. Email: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/125484; this version posted April 7, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Supplementary Information
    Electronic Supplementary Material (ESI) for ChemComm. This journal is © The Royal Society of Chemistry 2019 Supplementary Information Activity-based probe developed by sequential dehydroalanine formation strategy targets HECT E3 ubiquitin ligases Ling Xu,a, # Jian Fan,a, # Yu Wang,a,b Zhongping Zhang,c Yao Fu,a Yi-Ming Li,b* Jing Shi,a* a Department of Chemistry, University of Science and Technology of China; Hefei 230026, China, E-mail: [email protected] b School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui 230009, China, E-mail: [email protected]; c Institute of Intelligent Machines, Chinese Academy of Sciences, Hefei, Anhui 230031, China ‡ These authors contributed equally to this work. Table of Contents 1. General Information………………………………………………………………….…… S2 a. Materials b. HPLC and FPLC c. Molecular biochemistry d. Mass spectrometry e. Protein Expression and Purification 2. Experimental Section……………………………………………………………….……. S4 a. Chemical synthesis of Thz-Cysteine-thiol 4 b. Protein expression and purification c. Synthesis of biotinylated Ub(1-75)-CONHNH2 d. Synthesis of E2-Ub-Dha probe 9 e. Synthesis of E2-Ub conjugate 10 f. Protein folding and purification. g. Circular dichroism spectra determination h. Cross-linking between E2-Ub-Dha and GST-HECT of UBE3C and NEDD4 i. Proteins captured from Hela cell lysates j. LC-MS/MS identification E3 ligases captured by E2-Ub-Dha probe 3. Experimental figures……………………………………………………………….……. S9 S1 General Information a. Materials NaCl, NaNO2, Na2HPO4·12H2O, imidazole, guanidine hydrochloride (Gn·HCl) were purchased from Sinopharm Chemical Reagent. Tris(2-chloroethyl) phosphate (TCEP), 4-mercaptophenylacetic acid (MPAA), N,N-Diisopropylethylamine (DIEA) were purchased from Aladdin (Shanghai, China).
    [Show full text]
  • Downloaded a Meta
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.18.210328; this version posted April 12, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Dynamic regulatory module networks for inference of cell type-specific transcriptional networks Alireza Fotuhi Siahpirani1,2,+, Sara Knaack1+, Deborah Chasman1,8,+, Morten Seirup3,4, Rupa Sridharan1,5, Ron Stewart3, James Thomson3,5,6, and Sushmita Roy1,2,7* 1Wisconsin Institute for Discovery, University of Wisconsin-Madison 2Department of Computer Sciences, University of Wisconsin-Madison 3Morgridge Institute for Research 4Molecular and Environmental Toxicology Program, University of Wisconsin-Madison 5Department of Cell and Regenerative Biology, University of Wisconsin-Madison 6Department of Molecular, Cellular, & Developmental Biology, University of California Santa Barbara 7Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison 8Present address: Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Wisconsin-Madison +These authors contributed equally. *To whom correspondence should be addressed. 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.18.210328; this version posted April 12, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract Multi-omic datasets with parallel transcriptomic and epigenomic measurements across time or cell types are becoming increasingly common.
    [Show full text]